advancing innovation to save lives

GHTC launches call for nominations for Innovating for Impact Awards

GHTC is seeking nominations for its new Innovating for Impact Awards initiative to celebrate the research partnerships and political champions that help transform breakthrough scientific research into lifesaving drugs, vaccines, and other health tools for unmet global health challenges. Nominations will be accepted through September 20, 2017
Learn More

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Medicines for Malaria Venture

Medicines for Malaria Venture works with partners to discover, develop and accelerate delivery of new antimalarial therapies. In partnership, it has built the largest-ever portfolio of antimalarial drug projects and brought forward seven new medicines that are estimated to have saved over a million lives to date.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Aaron Joel Santos
Brink News picks up GE Reports article by GHTC director

Brink News picked up GE Report's article by Jamie Bay Nishi, GHTC director. The article examined on our new report Return on innovation: Why global health R&D is a smart investment for the United States.

Learn More
PATH/Gabe Bienczycki
GHTC director analyzes new GHTC report in GE Reports

GHTC Director Jamie Bay Nishi penned an article in GE Reports on how investment in global health R&D boosts the economy, using evidence on GHTC's new report Return on Innovation: Why global health is a smart investment for the United States.

Learn More
View All News & Events

Community Event

United Nations
72nd Session of the UN General Assembly (UNGA 72)
United Nations
Learn More

Community Event

PATH/Gabe Bienczycki
The Role of the Private Sector in Advancing Global Health
CSIS
Learn More
View All Events
New report shows a decline in funding for neglected disease R&D

Earlier today, the fourth annual G-FINDER report was released. This resource, developed by Policy Cures, is the only one of its kind that maps the global level of investment in developing new vaccines, drugs, diagnostics, and other tools that address 31 neglected diseases. This year’s report studies funding levels and trends in 2010.

GHTC
Read More
IPM receives USAID award to advance dual-purpose prevention ring for women

Luann Tia Blount is the Clinical Communications Officer for GHTC member the International Partnership for Microbicides (IPM), a nonprofit product development partnership dedicated to developing new HIV prevention technologies and making them available to women in developing countries. This post discusses novel approaches to HIV prevention, namely an adapted medical technology used to deliver hormones to women—the vaginal ring.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide